Abdera Therapeutics Alternatives & Competitors
12 companies similar to Abdera Therapeutics
Companies similar to Abdera Therapeutics
NBE-Therapeutics AG
Next generation antibody drug conjugates
Basel, Switzerland
Bicara Therapeutics
Pioneering bifunctional antibodies for targeted tumor modulation
Boston, United States
RayzeBio
Targeted innovative radiopharmaceuticals for cancer
San Diego, United States
Germany
Rival Readout
Competing with Abdera Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Neogene Therapeutics
Pushing the frontier by pioneering next-generation engineered T cell receptor therapies fo...
Amsterdam, The Netherland...
Incyclix Bio
Regaining Cell Cycle Control
Durham, United States
Kestrel Therapeutics
We aspire to invent brilliant technologies for difficult cancer targets, beginning with mu...
Watertown, United States
Arcellx
Arcellx is a clinical-stage biotechnology company based in Redwood City, California
Redwood City, United Stat...
2seventy bio
It’s about time we think smarter and faster than cancer.
Cambridge, United States
Mestag Therapeutics
New therapies for inflammatory disease and cancer by targeting fibroblast immunology
London, United Kingdom
Iovance Biotherapeutics, Inc.
Iovance is a patient-centric, collaborative organization that is driven to change the way...
San Carlos, United States
Synnovation Therapeutics
A precision oncology company focused on small molecule therapies optimized to target key d...
Wilmington, United States
About Abdera Therapeutics
Abdera Therapeutics Inc., founded in 2021, is a burgeoning player in the fields of Biotechnology, Health Care, and Life Sciences, with its headquarters in the United States. The company is at the forefront of developing next-generation targeted radiation therapies, utilizing a proprietary modular technology platform. T...
Development of radiotherapeutic cancer treatments, Antibody engineering for targeted drug delivery, Drug discovery for radiopharmaceuticals, Clinical trials for novel cancer therapies
Cancer patients (specifically SCLC and LCNEC), Healthcare providers, Oncologists, Pharmaceutical researchers
Precision Oncology, Targeted Radiation Therapies, Radioisotopes, Tumor Cell Destruction, Modular Technology Platform, Cancer Treatment, Innovative Drug Development, Team Growth, Medical Innovation, Cancer Therapy, Medical Technology, Cancer Research, Oncology Treatments
B2B, B2D
Licensing, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Abdera Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Abdera Therapeutics on 9 Jun 2026. The 12 companies listed here were last checked between 28 Jan 2026 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
